UNDERWRITING AGREEMENT between CHINA SXT PHARMACEUTICALS, INC. (the “Company”) and BOUSTEAD SECURITIES, LLC As Representative of the Underwriters (the “Representative”) CHINA SXT PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 17th, 2018 • China SXT Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The undersigned, China SXT Pharmaceuticals, Inc., a British Virgin Islands corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries of the Company, the “Company”), hereby confirms its agreement with BOUSTEAD SECURITIES, LLC. (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) with respect to the sale by the Company, through the Underwriter, on a best efforts basis, (the “Offering”) of a minimum of two million five hundred thousand (2,500,000) ordinary shares of the Company and a maximum of three million seven hundred and fifty thousand (3,750,000) ordinary shares of the Company (the “Placement Shares”), par value US$0.001 per share at an anticipated offering price of $4.00 per share per share for gross offering proceeds of $10,000,000 (based on a minimum offering) and $15,000,000 (based on a maximum offering), respectiv
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • August 17th, 2018 • China SXT Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this [__] day of [_____] 2018, by and among CHINA SXT PHARMACEUTICALS, INC., a British Virgin Islands company (the “Company”), having an address at 178 Taidong Rd North, Taizhou Jiangsu, China, Boustead Securities, LLC (the “Underwriter”), having an address at 6 Venture, Suite 325, Irvine CA 92618, and SIGNATURE BANK (the “Escrow Agent”), a New York State chartered bank, having an office at 950 Third Ave, 9th Floor, New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Prospectus, dated [______], 2018,including all attachments, schedules and exhibits thereto (the “Prospectus”).
